Thus, exploration and characterization of skeletal and neuronal BIN1-MPs may help identify new blood markers to aid accurate assessment of the health of skeletal muscle cells and neurons [41], as well as facilitate the development of new diagnostics and therapies for skeletal myopathy and Alzheimer’s disease. This evidence concerns the gene BIN1 and Alzheimer disease.